Home    eJManager.com Add Your Journal   |    Follow on Twitter

Directory for Medical Articles
 

Open Access

Editorial



Drug resistance TB in India: Challenges, issues and solutions

Deepak Saxena, Pankaj Bhardawaj.

Abstract
Multi Drug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) are emerging as a major challenges across globe including in India as narrated by the World Health Organization (WHO) for success the Stop TB strategy, launched in 2006.[1] MDR-TB is defined as tuberculosis disease where the bacilli is resistant to isoniazid (H) and rifampicin (R), with or without resistance to other drugs. Irregular consumption and frequent interruption in taking treatment for TB is the most common cause of acquiring multidrug resistance.

Key words: Drug resistance tuberculosis, Multi-drug resistance tuberculosis, Extensively drug resistance tuberculosis


Full text links

Share this Article





ScopeMed Home
Follow ScopeMed on Twitter
Article Tools
Job Opportunities/Service Offers
eJManager OJMS
eJPort Journal Hosting
About ScopeMed
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Service of eJManager LLC Publishing for Scientific Publications. Copyright © ScopeMedź International Medical Journal Management and Indexing System.
Scopemed Buttons